Pfizer and BioNTech Submit Emergency Use Authorization Application to FDA for Omicron Bivalent Vaccine
ADC评论
August 24, 2022
NEW YORK & MAINZ, Germany–(BUSINESS WIRE)– Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) today announced they have completed a submission to the U.S.
